Maravai Lifesciences Holdings (MRVI) Debt Ratio (2020 - 2026)

Maravai Lifesciences Holdings' Debt Ratio history runs 7 years deep, the most recent figure standing at 0.34 for Q1 2026.

• In Q1 2026, Debt Ratio rose 9.96% year-over-year to 0.34; the TTM figure through Mar 2026 stood at 0.34 (up 9.96% YoY), while the FY2025 annual figure was 0.38, up 29.0% from the prior year.
• Debt Ratio was 0.34 for Q1 2026 at Maravai Lifesciences Holdings, down from 0.38 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.41 in Q3 2024 to a low of 0.23 in Q4 2022.
• Historically, Debt Ratio has averaged 0.31 across 5 years, with a median of 0.33 in 2025.
• The sharpest annual moves came in 2023 and 2024: Debt Ratio tumbled 30.21% in 2023, then jumped 76.3% in 2024.
• A 5-year view of Debt Ratio shows it stood at 0.23 in 2022, then surged by 52.48% to 0.35 in 2023, then fell by 16.71% to 0.29 in 2024, then rose by 29.0% to 0.38 in 2025, then dropped by 10.75% to 0.34 in 2026.
• The last three Debt Ratio figures came in at 0.34 (Q1 2026), 0.38 (Q4 2025), and 0.34 (Q3 2025), per Business Quant data.